These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8363281)

  • 1. RNA drug therapy acting via the 2-5A synthetase/RNase L pathway.
    Suhadolnik RJ; Reichenbach NL; Hitzges PM; Ablashi DV; Strayer DR; Carter WA
    Ann N Y Acad Sci; 1993 Jun; 685():756-7. PubMed ID: 8363281
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.
    Suhadolnik RJ; Reichenbach NL; Hitzges P; Sobol RW; Peterson DL; Henry B; Ablashi DV; Müller WE; Schröder HC; Carter WA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S96-104. PubMed ID: 8148461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.
    Suhadolnik RJ; Reichenbach NL; Hitzges P; Adelson ME; Peterson DL; Cheney P; Salvato P; Thompson C; Loveless M; Müller WE
    In Vivo; 1994; 8(4):599-604. PubMed ID: 7893988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the antiretroviral effect of dsRNA.
    Müller WE; Ushijima H; Schröder HC
    Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome.
    Suhadolnik RJ; Peterson DL; O'Brien K; Cheney PR; Herst CV; Reichenbach NL; Kon N; Horvath SE; Iacono KT; Adelson ME; De Meirleir K; De Becker P; Charubala R; Pfleiderer W
    J Interferon Cytokine Res; 1997 Jul; 17(7):377-85. PubMed ID: 9243369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome.
    Snell CR; Vanness JM; Strayer DR; Stevens SR
    In Vivo; 2002; 16(2):107-9. PubMed ID: 12073768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase.
    Li SW; Moskow JJ; Suhadolnik RJ
    J Biol Chem; 1990 Apr; 265(10):5470-4. PubMed ID: 2318823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A.
    Silverman RH; Weiss SR
    J Interferon Cytokine Res; 2014 Jun; 34(6):455-63. PubMed ID: 24905202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase.
    Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC
    J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.
    Strayer DR; Carter WA; Brodsky I; Cheney P; Peterson D; Salvato P; Thompson C; Loveless M; Shapiro DE; Elsasser W
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S88-95. PubMed ID: 8148460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photolabeling of the enzymes of the 2-5A synthetase/RNase L/p68 kinase antiviral systems with azido probes.
    Suhadolnik RJ
    Prog Mol Subcell Biol; 1994; 14():260-75. PubMed ID: 7520331
    [No Abstract]   [Full Text] [Related]  

  • 12. High levels of 2',5'-oligoadenylate synthetase and 2',5'-oligoadenylate-dependent endonuclease in human trophoblast.
    Zhang GY; Beltchev B; Fournier A; Zhang YH; Malassiné A; Bisbal C; Ehresmann B; Ehresmann C; Darlix JL; Thang MN
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):189-96. PubMed ID: 8457385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell viability and the (2',5')oligo(A)-RNase L pathway in human colon carcinoma cells treated with human interferons and double-stranded RNA.
    Chapekar MS; Glazer RI
    Prog Clin Biol Res; 1985; 202():377-84. PubMed ID: 2421317
    [No Abstract]   [Full Text] [Related]  

  • 14. A misaligned double-stranded RNA, poly(I).poly(C12,U), induces accumulation of 2',5'-oligoadenylates in mouse tissues.
    Hearl WG; Johnston MI
    Biochem Biophys Res Commun; 1986 Jul; 138(1):40-6. PubMed ID: 2427076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide oligomerization domain-2 interacts with 2'-5'-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells.
    Dugan JW; Albor A; David L; Fowlkes J; Blackledge MT; Martin TM; Planck SR; Rosenzweig HL; Rosenbaum JT; Davey MP
    Mol Immunol; 2009 Dec; 47(2-3):560-6. PubMed ID: 19853919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNase L plays a role in the antiviral response to West Nile virus.
    Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
    J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic 2',5'-oligoadenylate synthetase is insensitive to dsRNA and interferon stimulation in autoimmune BB rats.
    Bonnevie-Nielsen V; Husum G; Kristiansen K
    J Interferon Res; 1991 Dec; 11(6):351-6. PubMed ID: 1800583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of 2',5'-oligoadenylate-dependent RNase expression in the human hepatoma cell line HepG2.
    Tnani M; Bayard BA
    Biochim Biophys Acta; 1998 Mar; 1402(2):139-50. PubMed ID: 9561800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.
    Anderson BR; Muramatsu H; Jha BK; Silverman RH; Weissman D; Karikó K
    Nucleic Acids Res; 2011 Nov; 39(21):9329-38. PubMed ID: 21813458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.
    Banerjee S; Gusho E; Gaughan C; Dong B; Gu X; Holvey-Bates E; Talukdar M; Li Y; Weiss SR; Sicheri F; Saunthararajah Y; Stark GR; Silverman RH
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5071-5076. PubMed ID: 30814222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.